Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DACTINOMYCIN vs DALBAVANCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DACTINOMYCIN vs DALBAVANCIN: Safety Overview

Metric DACTINOMYCIN DALBAVANCIN
Total FAERS Reports 2,858 1,107
Deaths Reported 507 54
Death Rate 17.7% 4.9%
Hospitalizations 721 288
Average Patient Age 18.8 yrs 61.0 yrs
% Female Patients 65.9% 46.7%
FDA Approval Date Approved Prior to Jan 1, 1982 May 23, 2014
Manufacturer Eugia US LLC Fresenius Kabi USA, LLC
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued Prescription